Rozen Le Panse

3.9k total citations
72 papers, 2.9k citations indexed

About

Rozen Le Panse is a scholar working on Neurology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Rozen Le Panse has authored 72 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Neurology, 20 papers in Endocrinology, Diabetes and Metabolism and 16 papers in Molecular Biology. Recurrent topics in Rozen Le Panse's work include Myasthenia Gravis and Thymoma (52 papers), Peripheral Neuropathies and Disorders (28 papers) and Adrenal Hormones and Disorders (14 papers). Rozen Le Panse is often cited by papers focused on Myasthenia Gravis and Thymoma (52 papers), Peripheral Neuropathies and Disorders (28 papers) and Adrenal Hormones and Disorders (14 papers). Rozen Le Panse collaborates with scholars based in France, United States and Netherlands. Rozen Le Panse's co-authors include Sonia Berrih‐Aknin, Frédérique Truffault, Nadine Dragin, Jacky Bismuth, Géraldine Cizeron-Clairac, Perrine Cufi, Élie Fadel, Julia Miriam Weiss, José Adolfo Villegas and Eva Cano and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Blood.

In The Last Decade

Rozen Le Panse

70 papers receiving 2.9k citations

Peers

Rozen Le Panse
Rozen Le Panse
Citations per year, relative to Rozen Le Panse Rozen Le Panse (= 1×) peers Bianca M. Conti‐Fine

Countries citing papers authored by Rozen Le Panse

Since Specialization
Citations

This map shows the geographic impact of Rozen Le Panse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rozen Le Panse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rozen Le Panse more than expected).

Fields of papers citing papers by Rozen Le Panse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rozen Le Panse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rozen Le Panse. The network helps show where Rozen Le Panse may publish in the future.

Co-authorship network of co-authors of Rozen Le Panse

This figure shows the co-authorship network connecting the top 25 collaborators of Rozen Le Panse. A scholar is included among the top collaborators of Rozen Le Panse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rozen Le Panse. Rozen Le Panse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pinzón, Natalia, Nadine Dragin, Aurélien Corneau, et al.. (2025). Mesenchymal stromal cells conditioned by peripheral blood mononuclear cells exert enhanced immunomodulation capacities and alleviate a model of Myasthenia Gravis. Stem Cell Research & Therapy. 16(1). 437–437. 1 indexed citations
2.
Martı́nez, Carmen, Elena Cortés‐Vicente, C. Juárez, et al.. (2024). Modified radioimmunoassay versus ELISA to quantify anti-acetylcholine receptor antibodies in a mouse model of myasthenia gravis. Journal of Immunological Methods. 534. 113748–113748. 1 indexed citations
3.
Kaminski, Henry J., Linda L. Kusner, Gary Cutter, et al.. (2024). Does Surgical Removal of the Thymus Have Deleterious Consequences?. Neurology. 102(12). e209482–e209482. 10 indexed citations
4.
Villegas, José Adolfo, Karen Matta, Frédérique Truffault, et al.. (2023). Blocking interleukin-23 ameliorates neuromuscular and thymic defects in myasthenia gravis. Journal of Neuroinflammation. 20(1). 9–9. 5 indexed citations
5.
Villegas, José Adolfo, et al.. (2020). Estrogen, estrogen-like molecules and autoimmune diseases. Autoimmunity Reviews. 19(3). 102468–102468. 61 indexed citations
6.
Truffault, Frédérique, Vincent Bondet, Darragh Duffy, et al.. (2019). Risk factors associated with myasthenia gravis in thymoma patients: The potential role of thymic germinal centers. Journal of Autoimmunity. 106. 102337–102337. 42 indexed citations
7.
Samson, Nolwenn, Frédérique Truffault, Maria Foti, et al.. (2018). Analysis of microRNA expression in the thymus of Myasthenia Gravis patients opens new research avenues. Autoimmunity Reviews. 17(6). 588–600. 30 indexed citations
8.
Villegas, José Adolfo, Jacky Bismuth, Frédérique Truffault, et al.. (2018). Il-23/Th17 cell pathway: A promising target to alleviate thymic inflammation maintenance in myasthenia gravis. Journal of Autoimmunity. 98. 59–73. 42 indexed citations
9.
Maurer, Marie, Fabien Le Grand, Élie Fadel, et al.. (2017). Muscle satellite cells are functionally impaired in myasthenia gravis: consequences on muscle regeneration. Acta Neuropathologica. 134(6). 869–888. 26 indexed citations
10.
Truffault, Frédérique, Vincent de Montpréville, B. Eymard, et al.. (2016). Thymic Germinal Centers and Corticosteroids in Myasthenia Gravis: an Immunopathological Study in 1035 Cases and a Critical Review. Clinical Reviews in Allergy & Immunology. 52(1). 108–124. 75 indexed citations
11.
Berrih‐Aknin, Sonia & Rozen Le Panse. (2014). Myasthenia gravis: A comprehensive review of immune dysregulation and etiological mechanisms. Journal of Autoimmunity. 52. 90–100. 263 indexed citations
12.
Weiss, Julia Miriam, Perrine Cufi, Rozen Le Panse, & Sonia Berrih‐Aknin. (2013). The thymus in autoimmune Myasthenia Gravis: Paradigm for a tertiary lymphoid organ. Revue Neurologique. 169(8-9). 640–649. 33 indexed citations
13.
Weiss, Julia Miriam, Perrine Cufi, Jacky Bismuth, et al.. (2012). SDF-1/CXCL12 recruits B cells and antigen-presenting cells to the thymus of autoimmune myasthenia gravis patients. Immunobiology. 218(3). 373–381. 51 indexed citations
14.
Panse, Rozen Le, Jacky Bismuth, Géraldine Cizeron-Clairac, et al.. (2010). Thymic remodeling associated with hyperplasia in myasthenia gravis. Autoimmunity. 43(5-6). 401–412. 62 indexed citations
15.
Vrolix, Kathleen, E. Niks, Rozen Le Panse, et al.. (2010). Reduced thymic expression of ErbB receptors without auto-antibodies against synaptic ErbB in myasthenia gravis. Journal of Neuroimmunology. 232(1-2). 158–165. 8 indexed citations
16.
Panse, Rozen Le, Géraldine Cizeron-Clairac, Frédérique Truffault, et al.. (2008). Regulatory and Pathogenic Mechanisms in Human Autoimmune Myasthenia Gravis. Annals of the New York Academy of Sciences. 1132(1). 135–142. 46 indexed citations
17.
Panse, Rozen Le, Géraldine Cizeron-Clairac, Jacky Bismuth, & Sonia Berrih‐Aknin. (2006). Microarrays Reveal Distinct Gene Signatures in the Thymus of Seropositive and Seronegative Myasthenia Gravis Patients and the Role of CC Chemokine Ligand 21 in Thymic Hyperplasia. The Journal of Immunology. 177(11). 7868–7879. 58 indexed citations
18.
Poëa‐Guyon, Sandrine, Premkumar Christadoss, Rozen Le Panse, et al.. (2005). Effects of Cytokines on Acetylcholine Receptor Expression: Implications for Myasthenia Gravis. The Journal of Immunology. 174(10). 5941–5949. 80 indexed citations
19.
Panse, Rozen Le & Sonia Berrih‐Aknin. (2005). Thymic myoid cells protect thymocytes from apoptosis and modulate their differentiation: implication of the ERK and Akt signaling pathways. Cell Death and Differentiation. 12(5). 463–472. 23 indexed citations
20.
Panse, Rozen Le, Bernard Coulomb, Vanio Mitev, et al.. (1994). Differential modulation of human fibroblast and keratinocyte growth by the protein kinase C inhibitor GF 109203X.. Molecular Pharmacology. 46(3). 445–451. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026